FGFR1 has been found to maintain the stem cell characteristics of cancer cells, through activation of MEK (mitogen-activated protein kinase kinase)/ERK pathways [76] and forkhead box protein M1 (FOXM1) pathway [77]. The gene discussed is WNK2; the disease is cancer.